Vihn Nguyen

Sulfasalazine decreases soluble fms-like tyrosine kinase-1 secretion potentially via inhibition of upstream placental epidermal growth factor receptor signalling.

N. Hannan, S. Tong, T. Kaitu'u-Lino, 2019, Placenta.

Inflammation modulates human HDL composition and function in vivo.

M. Reilly, N. Mehta, B. Asztalos, 2012, Atherosclerosis.

Sulfasalazine reduces placental secretion of antiangiogenic factors, up-regulates the secretion of placental growth factor and rescues endothelial dysfunction

L. Parry, N. Hannan, Sevvandi N. Senadheera, 2019, EBioMedicine.